These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34581751)

  • 41. Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial.
    Finn AF; Aaronson D; Korenblat P; Lumry W; Settipane G; Spector S; Woehler T; Drda K; Wood CC
    Am J Rhinol; 1998; 12(6):441-9. PubMed ID: 9883302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types.
    Ashford E; Salonen R; Saiers J; Woessner M
    Cephalalgia; 1998 Jun; 18(5):273-7. PubMed ID: 9673807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis.
    Nayak AS; Ellis MH; Gross GN; Mendelson LM; Schenkel EJ; Lanier BQ; Simpson B; Mullin ME; Smith JA
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):157-62. PubMed ID: 9500747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels.
    Hurt RD; Dale LC; Croghan GA; Croghan IT; Gomez-Dahl LC; Offord KP
    Mayo Clin Proc; 1998 Feb; 73(2):118-25. PubMed ID: 9472993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.
    Gourlay SG; Benowitz NL
    Clin Pharmacol Ther; 1997 Oct; 62(4):453-63. PubMed ID: 9357397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis.
    Holmberg K; Juliusson S; Balder B; Smith DL; Richards DH; Karlsson G
    Ann Allergy Asthma Immunol; 1997 Mar; 78(3):270-6. PubMed ID: 9087151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis.
    Munk ZM; LaForce C; Furst JA; Simpson B; Feiss G; Smith JA
    Ann Allergy Asthma Immunol; 1996 Oct; 77(4):277-81. PubMed ID: 8885803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
    Headache; 1995 Apr; 35(4):177-84. PubMed ID: 7775172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity.
    Graf P; Hallén H; Juto JE
    Acta Otolaryngol; 1995 Jan; 115(1):71-5. PubMed ID: 7762389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance.
    Kasper S; Cubała WJ; Fagiolini A; Ramos-Quiroga JA; Souery D; Young AH
    World J Biol Psychiatry; 2021 Jul; 22(6):468-482. PubMed ID: 33138665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of liposomal nasal spray with vitamins A and E on allergic rhinitis.
    Lauriello M; di Marco GP; Necozione S; Tucci C; Pasqua M; Rizzo G; Eibenstein A
    Acta Otorhinolaryngol Ital; 2020 Jun; 40(3):217-223. PubMed ID: 32773784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro assessment of an idealized nose for nasal spray testing: Comparison with regional deposition in realistic nasal replicas.
    Chen JZ; Kiaee M; Martin AR; Finlay WH
    Int J Pharm; 2020 May; 582():119341. PubMed ID: 32305365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB
    JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anesthetic Efficacy of Intranasal 3% Tetracaine plus 0.05% Oxymetazoline (Kovanaze) in Maxillary Teeth.
    Capetillo J; Drum M; Reader A; Fowler S; Nusstein J; Beck M
    J Endod; 2019 Mar; 45(3):257-262. PubMed ID: 30803532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Simplified Geometric Model to Predict Nasal Spray Deposition in Children and Adults.
    Foo MY; Sawant N; Overholtzer E; Donovan MD
    AAPS PharmSciTech; 2018 Oct; 19(7):2767-2777. PubMed ID: 29948982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis.
    Williams AJ; Jordan F; King G; Lewis AL; Illum L; Masud T; Perkins AC; Pearson RG
    Int J Pharm; 2018 Jan; 535(1-2):113-119. PubMed ID: 29038066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of nasal drug delivery device and its orientation on sprayed particle deposition in a realistic human nasal cavity.
    Tong X; Dong J; Shang Y; Inthavong K; Tu J
    Comput Biol Med; 2016 Oct; 77():40-8. PubMed ID: 27509293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
    Winner P; Farkas V; Štillová H; Woodruff B; Liss C; Lillieborg S; Raines S;
    Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect size comparison of ketorolac nasal spray and commonly prescribed oral combination opioids for pain relief after third molar extraction surgery.
    Niebler G; Dayno J
    Postgrad Med; 2016 Jan; 128(1):12-7. PubMed ID: 26616001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.